Skip to main content
. 2018 Jun 5;5(1):1478593. doi: 10.1080/20018525.2018.1478593

Table 3.

Association between baseline determinants and asthma score at follow up (OR per step increase), FEV₁ at baseline and FEV₁ at follow up (coeff.).

  Asthma score at follow up
FEV₁ at baseline (liter)
FEV₁ at follow up (liter)
Determinants, baseline OR (95%CI) Coefficient (95%CI) Coefficient (95%CI)
Sex, female 1.07 (0.65–1.74) 1.006 (−1.144−0.868) 0.050 (−0.050–0.151)
FEV₁ 1.026 (0.958–1.095)
FEV₁ below pred. 1.44 (0.78–2.66)
Bronchial hyperresponsiveness 1.37 (0.84–2.23) −0.014 (−0.149–0.121) −0.004 (−0.075–0.068)
ACOS 1.66 (0.88–3.11) −0.398 (−0.576−0.221) 0.025 (−0.072–0.123)
Asthma Score per step increase 1.60 (1.34–1.91) 0.007 (−0.042–0.055) −0.001 (−0.027–0.024)
Medication, 12 mth      
SABA only 1.50 (0.77–2.94) 0.046 (−0.138–0.231) 0.099 (0.002–0.196)
ICS and/or LABA 1.14 (0.63–2.08) 0.005 (−0.162–0.172) 0.029 (−0.059–0.117)
Current smoking 0.89 (0.51–1.57) −0.141 (−0.295–0.014) 0.020 (−0.062–0.102)
High-risk occupation (asthma)a 1.16 (0.31–4.28) 0.133 (−0.266–0.531) 0.076 (−0.134–0.285)
High-risk occupation (COPD) b 1.26 (0.34–4.68) −0.047 (−0.444–0.350) −0.042 (−0.250–0.167)

Bold values denote significant associations (p < 0.05).

an = 236; 3 participants had missing in variable ‘high-risk occupation (asthma)’.

bn = 236; 3 participants had missing in variable ‘high-risk occupation (COPD)’.

Regarding FEV₁ negative numbers report larger decrease. The table shows odds ratios (OR) and regression coefficients with 95% confidence intervals (95% CI).